BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26772212)

  • 1. Regulation of Immunity by Butyrophilins.
    Rhodes DA; Reith W; Trowsdale J
    Annu Rev Immunol; 2016 May; 34():151-72. PubMed ID: 26772212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology.
    Vantourout P; Laing A; Woodward MJ; Zlatareva I; Apolonia L; Jones AW; Snijders AP; Malim MH; Hayday AC
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1039-1044. PubMed ID: 29339503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrophilins: γδ T Cell Receptor Ligands, Immunomodulators and More.
    Herrmann T; Karunakaran MM
    Front Immunol; 2022; 13():876493. PubMed ID: 35371078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human γδ T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin.
    Rhodes DA; Chen HC; Price AJ; Keeble AH; Davey MS; James LC; Eberl M; Trowsdale J
    J Immunol; 2015 Mar; 194(5):2390-8. PubMed ID: 25637025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters.
    Rhodes DA; Chen HC; Williamson JC; Hill A; Yuan J; Smith S; Rhodes H; Trowsdale J; Lehner PJ; Herrmann T; Eberl M
    Front Immunol; 2018; 9():662. PubMed ID: 29670629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells.
    Payne KK; Mine JA; Biswas S; Chaurio RA; Perales-Puchalt A; Anadon CM; Costich TL; Harro CM; Walrath J; Ming Q; Tcyganov E; Buras AL; Rigolizzo KE; Mandal G; Lajoie J; Ophir M; Tchou J; Marchion D; Luca VC; Bobrowicz P; McLaughlin B; Eskiocak U; Schmidt M; Cubillos-Ruiz JR; Rodriguez PC; Gabrilovich DI; Conejo-Garcia JR
    Science; 2020 Aug; 369(6506):942-949. PubMed ID: 32820120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation.
    Arnett HA; Escobar SS; Gonzalez-Suarez E; Budelsky AL; Steffen LA; Boiani N; Zhang M; Siu G; Brewer AW; Viney JL
    J Immunol; 2007 Feb; 178(3):1523-33. PubMed ID: 17237401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
    Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
    Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BTNL8, a butyrophilin-like molecule that costimulates the primary immune response.
    Chapoval AI; Smithson G; Brunick L; Mesri M; Boldog FL; Andrew D; Khramtsov NV; Feshchenko EA; Starling GC; Mezes PS
    Mol Immunol; 2013 Dec; 56(4):819-28. PubMed ID: 24036152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extending the B7 (CD80) gene family.
    Linsley PS; Peach R; Gladstone P; Bajorath J
    Protein Sci; 1994 Aug; 3(8):1341-3. PubMed ID: 7527261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells.
    Swanson RM; Gavin MA; Escobar SS; Rottman JB; Lipsky BP; Dube S; Li L; Bigler J; Wolfson M; Arnett HA; Viney JL
    J Immunol; 2013 Mar; 190(5):2027-35. PubMed ID: 23359506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune modulation by butyrophilins.
    Arnett HA; Viney JL
    Nat Rev Immunol; 2014 Aug; 14(8):559-69. PubMed ID: 25060581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butyrophilins: Dynamic Regulators of Protective T Cell Immunity in Cancer.
    Kumari R; Hosseini ES; Warrington KE; Milonas T; Payne KK
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Disordered Regions and Their Roles in the Anti-Pathogenic and Immunomodulatory Functions of Butyrophilins.
    Redwan EM; Al-Hejin AM; Almehdar HA; Elsaway AM; Uversky VN
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29401697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.
    Harly C; Guillaume Y; Nedellec S; Peigné CM; Mönkkönen H; Mönkkönen J; Li J; Kuball J; Adams EJ; Netzer S; Déchanet-Merville J; Léger A; Herrmann T; Breathnach R; Olive D; Bonneville M; Scotet E
    Blood; 2012 Sep; 120(11):2269-79. PubMed ID: 22767497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.
    Peigné CM; Léger A; Gesnel MC; Konczak F; Olive D; Bonneville M; Breathnach R; Scotet E
    J Immunol; 2017 Jun; 198(11):4228-4234. PubMed ID: 28461569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells in teleost fish act as pivotal initiating APCs in priming adaptive immunity: an evolutionary perspective on the origin of the B-1 cell subset and B7 molecules.
    Zhu LY; Lin AF; Shao T; Nie L; Dong WR; Xiang LX; Shao JZ
    J Immunol; 2014 Mar; 192(6):2699-714. PubMed ID: 24532580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role for CD277 as a co-regulator of the immune signal in T and NK cells.
    Messal N; Mamessier E; Sylvain A; Celis-Gutierrez J; Thibult ML; Chetaille B; Firaguay G; Pastor S; Guillaume Y; Wang Q; Hirsch I; Nunès JA; Olive D
    Eur J Immunol; 2011 Dec; 41(12):3443-54. PubMed ID: 21918970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells.
    Cubillos-Ruiz JR; Martinez D; Scarlett UK; Rutkowski MR; Nesbeth YC; Camposeco-Jacobs AL; Conejo-Garcia JR
    Oncotarget; 2010 Sep; 1(5):329-38. PubMed ID: 21113407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness.
    Melandri D; Zlatareva I; Chaleil RAG; Dart RJ; Chancellor A; Nussbaumer O; Polyakova O; Roberts NA; Wesch D; Kabelitz D; Irving PM; John S; Mansour S; Bates PA; Vantourout P; Hayday AC
    Nat Immunol; 2018 Dec; 19(12):1352-1365. PubMed ID: 30420626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.